OR WAIT null SECS
July 21, 2005
Chiron Cuts Supply of Flu Vaccines Made in Germany; Liverpool Plant Under Inspection
May 02, 2005
Vaccine developers are using novel drug delivery methods that offer advantages over traditional techniques such as improved immunogenicity, better stability, specific control over antigen release, and a wider pool of targeted diseases.
Vaccine developers are wrking on new drug delivery systems that offer improved immune responses, better stability, and a wider pool of targeted diseases.
April 21, 2005
Crucell and NIH Sign Ebola Vaccine Manufacturing Contract
April 07, 2005
HHS Awards $97-Million Vaccine Development Contract
March 10, 2005
"Stable Liquid" Technology Permits Heptavalent Vaccine Against Botulism
March 03, 2005
UK MHRA Okays Chiron Flu Vaccine Plant; FDA Approval Still to Come
February 24, 2005
CBER Draft Guidance for Spore-Formers and Plasmid Vaccines
January 20, 2005
MHRA to Reinspect Chiron Flu Vaccine Plant
January 07, 2005
Engineered Oilbodies Produce Vaccines and Adjuvants